Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Kun-Han Lue"'
Autor:
Yu-Hung Chen, Tso-Fu Wang, Sung-Chao Chu, Chih-Bin Lin, Ling-Yi Wang, Kun-Han Lue, Shu-Hsin Liu, Sheng-Chieh Chan
Publikováno v:
PLoS ONE, Vol 15, Iss 12, p e0244502 (2020)
BackgroundTo investigate the survival prognostic value of the radiomic features of 18F-FDG PET in patients who had EGFR (epidermal growth factor receptor) mutated lung adenocarcinoma and received targeted TKI (tyrosine kinase inhibitor) treatment.Met
Externí odkaz:
https://doaj.org/article/98d0892eab2843ea8ac0f03e25a7a974
Autor:
Yu-Hung Chen, Sung-Chao Chu, Ling-Yi Wang, Tso-Fu Wang, Kun-Han Lue, Chih-Bin Lin, Bee-Song Chang, Dai-Wei Liu, Shu-Hsin Liu, Sheng-Chieh Chan
Publikováno v:
Diagnostics, Vol 11, Iss 6, p 1065 (2021)
We investigated whether the combination of primary tumor and nodal 18F-FDG PET parameters predict survival outcomes in patients with nodal metastatic non-small cell lung cancer (NSCLC) without distant metastasis. We retrospectively extracted pre-trea
Externí odkaz:
https://doaj.org/article/358b01a474e44abeb243fcd5c2a9a540
Autor:
Kun-Han Lue, Yi-Feng Wu, Hsin-Hon Lin, Tsung-Cheng Hsieh, Shu-Hsin Liu, Sheng-Chieh Chan, Yu-Hung Chen
Publikováno v:
Diagnostics, Vol 11, Iss 1, p 36 (2020)
This study investigates whether baseline 18F-FDG PET radiomic features can predict survival outcomes in patients with diffuse large B-cell lymphoma (DLBCL). We retrospectively enrolled 83 patients diagnosed with DLBCL who underwent 18F-FDG PET scans
Externí odkaz:
https://doaj.org/article/d84fc7e9bebd4124ace0df129da5b6e2
Autor:
Kun-Han Lue, 呂昆翰
99
6-[F-18]Fluoro-L-DOPA (FDOPA) is a radiopharmaceutical valuable for assessing the presynaptic dopaminergic function when used with positron emission tomography (PET). More specifically, the striatal-to-occipital ratio (SOR) of FDOPA uptake im
6-[F-18]Fluoro-L-DOPA (FDOPA) is a radiopharmaceutical valuable for assessing the presynaptic dopaminergic function when used with positron emission tomography (PET). More specifically, the striatal-to-occipital ratio (SOR) of FDOPA uptake im
Externí odkaz:
http://ndltd.ncl.edu.tw/handle/54124052440016539924
Autor:
Yu-Hung Chen, Yen-Chang Chen, Kun-Han Lue, Sung-Chao Chu, Bee-Song Chang, Ling-Yi Wang, Ming-Hsun Li, Chih-Bin Lin
Publikováno v:
Annals of Nuclear Medicine. 37:139-150
We investigated whether glycolytic heterogeneity correlated with histopathology, and further stratified the survival outcomes pertaining to resectable lung adenocarcinoma.We retrospectively analyzed theEntropy significantly correlated with histopatho
Publikováno v:
Nuclear Medicine Communications. 44:74-80
The total metabolic tumor volume (TMTV) measured from fluorine-18 fluorodeoxyglucose (18F-FDG) PET can be useful for determining the prognosis of patients with lymphoma. Stratifying patients into high- and low-TMTV risk groups requires a cutoff point
Autor:
Kun-Han Lue, Yu-Hung Chen, Sung-Chao Chu, Bee-Song Chang, Chih-Bin Lin, Yen-Chang Chen, Hsin-Hon Lin, Shu-Hsin Liu
Publikováno v:
Nuclear Medicine Communications; Dec2023, Vol. 44 Issue 12, p1094-1105, 12p
Autor:
Yu-Hung Chen, Kun-Han Lue, Chih-Bin Lin, Kuang-Chi Chen, Sheng-Chieh Chan, Sung-Chao Chu, Bee-Song Chang, Yen-Chang Chen
Publikováno v:
International Journal of Molecular Sciences
Volume 24
Issue 4
Pages: 3988
Volume 24
Issue 4
Pages: 3988
Radiogenomic heterogeneity features in 18F-fluorodeoxyglucose positron emission tomography (18F-FDG PET) have become popular in non-small cell lung cancer (NSCLC) research. However, the reliabilities of genomic heterogeneity features and of PET-based
Autor:
Chih-Bin Lin, Ming-Hsun Li, Sung-Chao Chu, Shu-Hsin Liu, Kun-Han Lue, Yen-Chang Chen, Bee-Song Chang, Sheng-Chieh Chan, Ling-Yi Wang, Yu-Hung Chen
Publikováno v:
Annals of Nuclear Medicine. 36:256-266
The diagnostic performance of 18F-FDG PET for detecting regional lymph node metastasis in resectable lung cancer is variable, and its sensitivity for adenocarcinoma is even lower. We aimed to evaluate the value of 18F-FDG PET-derived features in pred
Publikováno v:
Nuclear medicine communications.
To investigate whether combining primary tumor and metastatic nodal glycolytic heterogeneity on 18F-fluorodeoxyglucose PET (18F-FDG PET) improves prognostic prediction in nonsmall cell lung cancer (NSCLC) with locoregional disease.We retrospectively